Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts

Oncogenes and Tumor Suppressors

Citations 1-10 of 795 total displayed.

Most recent content (1 May 2008):

The recurrent SET-NUP214 fusion as a new HOXA activation mechanism in pediatric T-cell acute lymphoblastic leukemia
Pieter Van Vlierberghe, Martine van Grotel, Joëlle Tchinda, Charles Lee, H. Berna Beverloo, Peter J. van der Spek, Andrew Stubbs, Jan Cools, Kyosuke Nagata, Maarten Fornerod, Jessica Buijs-Gladdines, Martin Horstmann, Elisabeth R. van Wering, Jean Soulier, Rob Pieters, and Jules P. P. Meijerink
Blood 2008; 111: 4668-4680. [Abstract] [Full text] [PDF]  

Requirement of c-Myb for p210BCR/ABL-dependent transformation of hematopoietic progenitors and leukemogenesis
Maria Rosa Lidonnici, Francesca Corradini, Todd Waldron, Timothy P. Bender, and Bruno Calabretta
Blood 2008; 111: 4771-4779. [Abstract] [Full text] [PDF]  

High-throughput sequence analysis of the tyrosine kinome in acute myeloid leukemia
Marc M. Loriaux, Ross L. Levine, Jeffrey W. Tyner, Stefan Fröhling, Claudia Scholl, Eric P. Stoffregen, Gerlinde Wernig, Heidi Erickson, Christopher A. Eide, Roland Berger, Olivier A. Bernard, James D. Griffin, Richard M. Stone, Benjamin Lee, Matthew Meyerson, Michael C. Heinrich, Michael W. Deininger, D. Gary Gilliland, and Brian J. Druker
Blood 2008; 111: 4788-4796. [Abstract] [Full text] [PDF]  

Somatic mutations and germline sequence variants in the expressed tyrosine kinase genes of patients with de novo acute myeloid leukemia
Michael H. Tomasson, Zhifu Xiang, Richard Walgren, Yu Zhao, Yumi Kasai, Tracie Miner, Rhonda E. Ries, Olga Lubman, Daved H. Fremont, Michael D. McLellan, Jacqueline E. Payton, Peter Westervelt, John F. DiPersio, Daniel C. Link, Matthew J. Walter, Timothy A. Graubert, Mark Watson, Jack Baty, Sharon Heath, William D. Shannon, Rakesh Nagarajan, Clara D. Bloomfield, Elaine R. Mardis, Richard K. Wilson, and Timothy J. Ley
Blood 2008; 111: 4797-4808. [Abstract] [Full text] [PDF]  

Identification of somatic JAK1 mutations in patients with acute myeloid leukemia
Zhifu Xiang, Yu Zhao, Vesselin Mitaksov, Daved H. Fremont, Yumi Kasai, AnnaLynn Molitoris, Rhonda E. Ries, Tracie L. Miner, Michael D. McLellan, John F. DiPersio, Daniel C. Link, Jacqueline E. Payton, Timothy A. Graubert, Mark Watson, William Shannon, Sharon E. Heath, Rakesh Nagarajan, Elaine R. Mardis, Richard K. Wilson, Timothy J. Ley, and Michael H. Tomasson
Blood 2008; 111: 4809-4812. [Abstract] [Full text] [PDF]  

Past content (since May 2000):

Ratio of mutant JAK2-V617F to wild-type Jak2 determines the MPD phenotypes in transgenic mice
Ralph Tiedt, Hui Hao-Shen, Marta A. Sobas, Renate Looser, Stephan Dirnhofer, Jürg Schwaller, and Radek C. Skoda
Blood 2008; 111: 3931-3940. [Abstract] [Full text] [PDF]  

Runx1 is involved in primitive erythropoiesis in the mouse
Tomomasa Yokomizo, Kazuteru Hasegawa, Hiroyuki Ishitobi, Motomi Osato, Masatsugu Ema, Yoshiaki Ito, Masayuki Yamamoto, and Satoru Takahashi
Blood 2008; 111: 4075-4080. [Abstract] [Full text] [PDF]  

Leukemia-associated NF1 inactivation in patients with pediatric T-ALL and AML lacking evidence for neurofibromatosis
Brian V. Balgobind, Pieter Van Vlierberghe, Ans M. W. van den Ouweland, H. Berna Beverloo, Joan N. R. Terlouw-Kromosoeto, Elisabeth R. van Wering, Dirk Reinhardt, Martin Horstmann, Gertjan J. L. Kaspers, Rob Pieters, C. Michel Zwaan, Marry M. Van den Heuvel-Eibrink, and Jules P. P. Meijerink
Blood 2008; 111: 4322-4328. [Abstract] [Full text] [PDF]  

High EVI1 levels predict adverse outcome in acute myeloid leukemia: prevalence of EVI1 overexpression and chromosome 3q26 abnormalities underestimated
Sanne Lugthart, Ellen van Drunen, Yvette van Norden, Antoinette van Hoven, Claudia A. J. Erpelinck, Peter J. M. Valk, H. Berna Beverloo, Bob Löwenberg, and Ruud Delwel
Blood 2008; 111: 4329-4337. [Abstract] [Full text] [PDF]  

Simultaneous targeting of Aurora kinases and Bcr-Abl kinase by the small molecule inhibitor PHA-739358 is effective against imatinib-resistant BCR-ABL mutations including T315I
Artur Gontarewicz, Stefan Balabanov, Gunhild Keller, Riccardo Colombo, Alessio Graziano, Enrico Pesenti, Daniel Benten, Carsten Bokemeyer, Walter Fiedler, Jürgen Moll, and Tim H. Brümmendorf
Blood 2008; 111: 4355-4364. [Abstract] [Full text] [PDF]  

[Next page]
Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80

* Sign up for Collection Alerts

* Collected Resources Home

* Related collections:
 Physiology Collections
 Apoptosis
 Cell Adhesion and Motility
 Cell Cycle
 Cytoskeleton
 Gene Expression
 Genomics
 Immunotherapy
 Oncogenes and Tumor Suppressors
 Signal Transduction

 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2009 by American Society of Hematology         Online ISSN: 1528-0020